Centene Corporation (CNC) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Centene Corporation (CNC) Healthcare & Pipeline Overview

Centene Corporation, a key player in the healthcare sector, provides managed care and specialty services, primarily focusing on government-subsidized programs like Medicaid and Medicare. With a national presence, Centene addresses the needs of under-insured and uninsured populations through diverse health plans and specialized offerings.

What Is the Investment Thesis for CNC?

Centene Corporation presents a mixed investment thesis. The company's focus on government-subsidized healthcare programs provides a stable revenue base, but its negative profit margin of -3.3% raises concerns about profitability. Growth catalysts include expanding Medicaid and Medicare programs and increasing demand for specialty healthcare services. The company's low beta of 0.59 suggests lower volatility compared to the broader market. However, potential risks include regulatory changes, reimbursement pressures, and competition within the managed care industry. Investors should closely monitor Centene's ability to improve its profit margins and navigate the evolving healthcare landscape.

Based on FMP financials and quantitative analysis

CNC Key Highlights

Centene operates in the Healthcare sector, specifically within Medical - Healthcare Plans.

• The company has a market capitalization of $32.3B.
• Centene employs approximately 60,400 individuals.
• The company's gross margin is 14.9%.
• Centene's beta is 0.59, indicating lower volatility compared to the market.

Who Are CNC's Competitors?

CNC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CNC's Key Strengths?

Strong presence in government-sponsored healthcare programs.

• Diversified service offerings across managed care and specialty services.
• Extensive network of providers and healthcare facilities.
• Experienced management team with expertise in healthcare administration.

What Are CNC's Weaknesses?

Negative profit margin raises concerns about profitability.

• Exposure to regulatory changes and reimbursement pressures.
• High dependence on government funding.
• Intense competition in the managed care industry.

What Could Drive CNC Stock Higher?

Potential for increased enrollment in Medicaid and Medicare programs due to economic conditions.

• Expansion of telehealth and digital health solutions to improve access to care.
• Strategic partnerships with healthcare providers to implement value-based care models.

What Are the Key Risks for CNC?

Negative return on equity (-28.7%) — the business is not currently generating profit on shareholder capital.

• Insider selling — insiders were net sellers of roughly $12.1M recently.
• Regulatory changes that could impact reimbursement rates.
• Increased competition from other managed care providers.
• Rising healthcare costs and utilization rates.
• Cybersecurity threats and data breaches.

What Are the Growth Opportunities for CNC?

• Expansion of Medicaid and Medicare Programs: The ongoing expansion of Medicaid and Medicare programs presents a significant growth opportunity for Centene. As more states expand Medicaid eligibility and the Medicare population continues to grow, Centene can leverage its expertise in managing government-sponsored healthcare plans to increase its membership and revenue. This expansion is an ongoing catalyst.
• Increased Demand for Specialty Services: The growing demand for specialty healthcare services, such as pharmacy benefits management, vision and dental care, and behavioral health services, provides another avenue for growth. Centene's Specialty Services segment is well-positioned to capitalize on this trend by offering a comprehensive suite of services to state programs, correctional facilities, healthcare organizations, and employer groups. The market for specialty healthcare services is estimated to be worth billions of dollars annually, offering ample opportunities for Centene to expand its market share. This is an ongoing opportunity.
• Strategic Acquisitions and Partnerships: Centene can pursue strategic acquisitions and partnerships to expand its geographic reach, enhance its service offerings, and gain access to new markets. Acquiring smaller healthcare providers or partnering with innovative technology companies can strengthen Centene's competitive position and drive long-term growth. The healthcare industry is ripe with acquisition targets and partnership opportunities, allowing Centene to selectively pursue deals that align with its strategic objectives. This is an ongoing opportunity.
• Technological Innovation and Digital Health Solutions: Investing in technological innovation and digital health solutions can improve efficiency, enhance patient engagement, and reduce costs. Centene can leverage telehealth, mobile health apps, and data analytics to provide more convenient and personalized care to its members. The digital health market is experiencing rapid growth, with increasing adoption of telehealth and remote monitoring technologies. Centene can capitalize on this trend by developing and implementing innovative digital health solutions. This is an ongoing opportunity.
• Focus on Value-Based Care: Shifting towards value-based care models, which emphasize quality and outcomes over volume, can improve patient satisfaction, reduce costs, and enhance Centene's reputation. By partnering with healthcare providers to implement value-based care programs, Centene can align incentives and drive better health outcomes for its members. The transition to value-based care is a major trend in the healthcare industry, and Centene can position itself as a leader in this area. This is an ongoing opportunity.

What Are CNC's Competitive Advantages?

• Scale and market share in government-sponsored healthcare programs.
• Established relationships with state and federal government agencies.
• Comprehensive suite of managed care and specialty services.
• Expertise in managing complex populations with diverse healthcare needs.

What Does CNC Do?

Founded in 1984 and headquartered in St. Louis, Missouri, Centene Corporation has evolved into a multi-national healthcare enterprise dedicated to providing healthcare programs and services to under-insured and uninsured individuals. The company operates through two primary segments: Managed Care and Specialty Services. The Managed Care segment offers health plan coverage through government-subsidized programs, including Medicaid, the State Children's Health Insurance Program (CHIP), long-term services and support, foster care, and Medicare-Medicaid plans. These plans encompass a wide array of services, from primary and specialty physician care to inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray services, home-based primary care, transportation assistance, vision and dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services. Additionally, the segment provides individual, small group, and large group commercial healthcare products. The Specialty Services segment delivers pharmacy benefits management, nurse advice line and after-hours support, vision and dental services, staffing services to correctional systems and government agencies, and services to Military Health System beneficiaries. Centene serves state programs, correctional facilities, healthcare organizations, employer groups, and other commercial entities, utilizing a network of primary and specialty care physicians, hospitals, and ancillary providers.

What Products and Services Does CNC Offer?

• Provides health plan coverage through government-subsidized programs like Medicaid and Medicare.
• Offers individual, small group, and large group commercial healthcare products.
• Delivers pharmacy benefits management services.
• Provides nurse advice line and after-hours support services.
• Offers vision and dental services.
• Provides staffing services to correctional systems and other government agencies.
• Serves Military Health System eligible beneficiaries.

How Does CNC Make Money?

• Generates revenue from premiums paid by members enrolled in its health plans.
• Receives payments from government entities for managing Medicaid and Medicare programs.
• Earns fees for providing specialty services, such as pharmacy benefits management and vision and dental care.
• Manages healthcare costs through negotiated rates with providers and utilization management programs.

What Industry Does CNC Operate In?

Centene operates in the dynamic healthcare plans industry, which is characterized by increasing demand for managed care services, driven by the aging population and the expansion of government-sponsored healthcare programs. The industry is highly competitive, with major players vying for market share through product innovation, cost containment, and strategic acquisitions. Regulatory changes and reimbursement pressures pose ongoing challenges. Centene's focus on government-subsidized programs positions it to capitalize on the growing demand for Medicaid and Medicare plans, but it must effectively manage costs and navigate the complex regulatory environment to maintain profitability.

Who Are CNC's Key Customers?

• Under-insured and uninsured individuals.
• Individuals enrolled in Medicaid and Medicare programs.
• Employers offering commercial healthcare products to their employees.
• State programs and correctional facilities.
• Military Health System beneficiaries.

Company Profile

Centene Corporation operates in the Medical - Healthcare Plans industry within the Healthcare sector. It is headquartered in St. Louis, US. The company is led by CEO Sarah McGinty London. CNC has traded publicly since 2001.

Return on equity for Centene Corporation stands at -28.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -7.9%, showing how much profit it generates from its asset base. Its free cash flow yield is 20.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.12 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -20.4%, the inverse of the P/E and a quick read on earnings relative to price.

CNC Valuation & Market Position

With a $32.3B market cap, Centene Corporation sits in the large-cap segment of the market. Analyst price targets span from $39.00 to $80.00, with a consensus of $68.29. At the current price of $65.40, that implies approximately 4% upside potential. Relative to its peer group, CNC's quantitative score of 71/100 is roughly in line with the peer average of 74/100.

Quarterly Financial Performance: Centene Corporation

Revenue for Centene Corporation came in at $44.38B during Q2 FY2026, a 11.2% contraction versus the preceding quarter. The company recorded net income of $1.09B, with diluted EPS of $2.19. Quarter-over-quarter revenue has been mixed, typical for a large-cap company operating in Healthcare. Across the four most recent quarters, CNC averaged $-2.61 in diluted EPS.

Centene Corporation's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.77 places it in the grey zone, a middle ground that warrants monitoring.

Centene Corporation has beaten Wall Street's EPS estimate in 7 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 63.1% above estimates on average.

Over the past six months, Centene Corporation insiders filed 26 SEC Form 4 transactions — 6 sales and 20 purchases. On net that is roughly 138K shares disposed (about $12.1M), a signal worth weighing alongside the fundamentals.

CNC Financials

Next earnings report: Oct 27, 2026

CNC Latest News

CNC Analyst Consensus

CNC MoonshotScore

Latest Centene Corporation Analysis

Common Questions About CNC (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources